Ultrastructural changes in diaphragm neuromuscular junctions in a severe mouse model for Spinal Muscular Atrophy and their prevention by bifunctional U7 snRNA correcting SMN2 splicing - PubMed (original) (raw)
. 2010 Nov;20(11):744-52.
doi: 10.1016/j.nmd.2010.06.010. Epub 2010 Sep 15.
Affiliations
- PMID: 20832308
- DOI: 10.1016/j.nmd.2010.06.010
Ultrastructural changes in diaphragm neuromuscular junctions in a severe mouse model for Spinal Muscular Atrophy and their prevention by bifunctional U7 snRNA correcting SMN2 splicing
Tilman Voigt et al. Neuromuscul Disord. 2010 Nov.
Abstract
In Spinal Muscular Atrophy (SMA), the SMN1 gene is deleted or inactivated. Because of a splicing problem, the second copy gene, SMN2, generates insufficient amounts of functional SMN protein, leading to the death of spinal cord motoneurons. For a "severe" mouse SMA model (Smn -/-, hSMN2 +/+; with affected pups dying at 5-7 days), which most closely mimicks the genetic set-up in human SMA patients, we characterise SMA-related ultrastructural changes in neuromuscular junctions (NMJs) of two striated muscles with discrete functions. In the diaphragm, but not the soleus muscle of 4-days old SMA mice, mitochondria on both sides of the NMJs degenerate, and perisynaptic Schwann cells as well as endoneurial fibroblasts show striking changes in morphology. Importantly, NMJs of SMA mice in which a modified U7 snRNA corrects SMN2 splicing and delays or prevents SMA symptoms are normal. This ultrastructural study reveals novel features of NMJ alterations - in particular the involvement of perisynaptic Schwann cells - that may be relevant for human SMA pathogenesis.
Copyright © 2010 Elsevier B.V. All rights reserved.
Similar articles
- The craniosacral progression of muscle development influences the emergence of neuromuscular junction alterations in a severe murine model for spinal muscular atrophy.
Voigt T, Neve A, Schümperli D. Voigt T, et al. Neuropathol Appl Neurobiol. 2014 Jun;40(4):416-34. doi: 10.1111/nan.12064. Neuropathol Appl Neurobiol. 2014. PMID: 23718187 - Defective neuromuscular junction organization and postnatal myogenesis in mice with severe spinal muscular atrophy.
Dachs E, Hereu M, Piedrafita L, Casanovas A, Calderó J, Esquerda JE. Dachs E, et al. J Neuropathol Exp Neurol. 2011 Jun;70(6):444-61. doi: 10.1097/NEN.0b013e31821cbd8b. J Neuropathol Exp Neurol. 2011. PMID: 21572339 - Development and characterization of an SMN2-based intermediate mouse model of Spinal Muscular Atrophy.
Cobb MS, Rose FF, Rindt H, Glascock JJ, Shababi M, Miller MR, Osman EY, Yen PF, Garcia ML, Martin BR, Wetz MJ, Mazzasette C, Feng Z, Ko CP, Lorson CL. Cobb MS, et al. Hum Mol Genet. 2013 May 1;22(9):1843-55. doi: 10.1093/hmg/ddt037. Epub 2013 Feb 5. Hum Mol Genet. 2013. PMID: 23390132 - At the "junction" of spinal muscular atrophy pathogenesis: the role of neuromuscular junction dysfunction in SMA disease progression.
Goulet BB, Kothary R, Parks RJ. Goulet BB, et al. Curr Mol Med. 2013 Aug;13(7):1160-74. doi: 10.2174/15665240113139990044. Curr Mol Med. 2013. PMID: 23514457 Review. - Therapeutics development for spinal muscular atrophy.
Sumner CJ. Sumner CJ. NeuroRx. 2006 Apr;3(2):235-45. doi: 10.1016/j.nurx.2006.01.010. NeuroRx. 2006. PMID: 16554261 Free PMC article. Review.
Cited by
- Antisense-mediated RNA targeting: versatile and expedient genetic manipulation in the brain.
Zalachoras I, Evers MM, van Roon-Mom WM, Aartsma-Rus AM, Meijer OC. Zalachoras I, et al. Front Mol Neurosci. 2011 Jul 19;4:10. doi: 10.3389/fnmol.2011.00010. eCollection 2011. Front Mol Neurosci. 2011. PMID: 21811437 Free PMC article. - Mechanistic principles of antisense targets for the treatment of spinal muscular atrophy.
Singh NN, Lee BM, DiDonato CJ, Singh RN. Singh NN, et al. Future Med Chem. 2015;7(13):1793-808. doi: 10.4155/fmc.15.101. Epub 2015 Sep 18. Future Med Chem. 2015. PMID: 26381381 Free PMC article. Review. - Self-oligomerization regulates stability of survival motor neuron protein isoforms by sequestering an SCFSlmb degron.
Gray KM, Kaifer KA, Baillat D, Wen Y, Bonacci TR, Ebert AD, Raimer AC, Spring AM, Have ST, Glascock JJ, Gupta K, Van Duyne GD, Emanuele MJ, Lamond AI, Wagner EJ, Lorson CL, Matera AG. Gray KM, et al. Mol Biol Cell. 2018 Jan 15;29(2):96-110. doi: 10.1091/mbc.E17-11-0627. Epub 2017 Nov 22. Mol Biol Cell. 2018. PMID: 29167380 Free PMC article. - Model systems of motor neuron diseases as a platform for studying pathogenic mechanisms and searching for therapeutic agents.
Valetdinova KR, Medvedev SP, Zakian SM. Valetdinova KR, et al. Acta Naturae. 2015 Jan-Mar;7(1):19-36. Acta Naturae. 2015. PMID: 25926999 Free PMC article. - Splicing changes in SMA mouse motoneurons and SMN-depleted neuroblastoma cells: evidence for involvement of splicing regulatory proteins.
Huo Q, Kayikci M, Odermatt P, Meyer K, Michels O, Saxena S, Ule J, Schümperli D. Huo Q, et al. RNA Biol. 2014;11(11):1430-46. doi: 10.1080/15476286.2014.996494. RNA Biol. 2014. PMID: 25692239 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases